301 related articles for article (PubMed ID: 24062354)
1. Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans.
Vamvini MT; Aronis KN; Panagiotou G; Huh JY; Chamberland JP; Brinkoetter MT; Petrou M; Christophi CA; Kales SN; Christiani DC; Mantzoros CS
Eur J Endocrinol; 2013 Dec; 169(6):829-34. PubMed ID: 24062354
[TBL] [Abstract][Full Text] [Related]
2. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.
Huh JY; Panagiotou G; Mougios V; Brinkoetter M; Vamvini MT; Schneider BE; Mantzoros CS
Metabolism; 2012 Dec; 61(12):1725-38. PubMed ID: 23018146
[TBL] [Abstract][Full Text] [Related]
3. Metabolism: Irisin, the metabolic syndrome and follistatin in humans.
Boström PA; Fernández-Real JM
Nat Rev Endocrinol; 2014 Jan; 10(1):11-2. PubMed ID: 24247218
[No Abstract] [Full Text] [Related]
4. Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats.
Roberts MD; Bayless DS; Company JM; Jenkins NT; Padilla J; Childs TE; Martin JS; Dalbo VJ; Booth FW; Rector RS; Laughlin MH
Metabolism; 2013 Aug; 62(8):1052-6. PubMed ID: 23498898
[TBL] [Abstract][Full Text] [Related]
5. Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD with similar to CK-MB accuracy.
Anastasilakis AD; Koulaxis D; Kefala N; Polyzos SA; Upadhyay J; Pagkalidou E; Economou F; Anastasilakis CD; Mantzoros CS
Metabolism; 2017 Aug; 73():1-8. PubMed ID: 28732565
[TBL] [Abstract][Full Text] [Related]
6. Circulating Follistatin and Activin A and Their Regulation by Insulin in Obesity and Type 2 Diabetes.
Sylow L; Vind BF; Kruse R; Møller PM; Wojtaszewski JFP; Richter EA; Højlund K
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112102
[TBL] [Abstract][Full Text] [Related]
7. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans.
Norheim F; Langleite TM; Hjorth M; Holen T; Kielland A; Stadheim HK; Gulseth HL; Birkeland KI; Jensen J; Drevon CA
FEBS J; 2014 Feb; 281(3):739-49. PubMed ID: 24237962
[TBL] [Abstract][Full Text] [Related]
8. Effects of Roux-en-Y gastric bypass on circulating follistatin, activin A, and peripheral ActRIIB signaling in humans with obesity and type 2 diabetes.
Pham TCP; Bojsen-Møller KN; Madsbad S; Wojtaszewski JFP; Richter EA; Sylow L
Int J Obes (Lond); 2021 Feb; 45(2):316-325. PubMed ID: 32873911
[TBL] [Abstract][Full Text] [Related]
9. Circulating irisin levels and muscle FNDC5 mRNA expression are independent of IL-15 levels in mice.
Quinn LS; Anderson BG; Conner JD; Wolden-Hanson T
Endocrine; 2015 Nov; 50(2):368-77. PubMed ID: 25920499
[TBL] [Abstract][Full Text] [Related]
10. SMAD3 negatively regulates serum irisin and skeletal muscle FNDC5 and peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) during exercise.
Tiano JP; Springer DA; Rane SG
J Biol Chem; 2015 Mar; 290(12):7671-84. PubMed ID: 25648888
[TBL] [Abstract][Full Text] [Related]
11. FNDC5 relates to skeletal muscle IGF-I and mitochondrial function and gene expression in obese men with reduced growth hormone.
Srinivasa S; Suresh C; Mottla J; Hamarneh SR; Irazoqui JE; Frontera W; Torriani M; Stanley T; Makimura H
Growth Horm IGF Res; 2016 Feb; 26():36-41. PubMed ID: 26774404
[TBL] [Abstract][Full Text] [Related]
12. Energy deprivation alters in a leptin- and cortisol-independent manner circulating levels of activin A and follistatin but not myostatin in healthy males.
Vamvini MT; Aronis KN; Chamberland JP; Mantzoros CS
J Clin Endocrinol Metab; 2011 Nov; 96(11):3416-23. PubMed ID: 21865351
[TBL] [Abstract][Full Text] [Related]
13. Exercise-mimicking treatment fails to increase Fndc5 mRNA & irisin secretion in primary human myotubes.
Kurdiova T; Balaz M; Mayer A; Maderova D; Belan V; Wolfrum C; Ukropec J; Ukropcova B
Peptides; 2014 Jun; 56():1-7. PubMed ID: 24642356
[TBL] [Abstract][Full Text] [Related]
14. Irisin and FNDC5: effects of 12-week strength training, and relations to muscle phenotype and body mass composition in untrained women.
Ellefsen S; Vikmoen O; Slettaløkken G; Whist JE; Nygaard H; Hollan I; Rauk I; Vegge G; Strand TA; Raastad T; Rønnestad BR
Eur J Appl Physiol; 2014 Sep; 114(9):1875-88. PubMed ID: 24906447
[TBL] [Abstract][Full Text] [Related]
15. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health?
Pekkala S; Wiklund PK; Hulmi JJ; Ahtiainen JP; Horttanainen M; Pöllänen E; Mäkelä KA; Kainulainen H; Häkkinen K; Nyman K; Alén M; Herzig KH; Cheng S
J Physiol; 2013 Nov; 591(21):5393-400. PubMed ID: 24000180
[TBL] [Abstract][Full Text] [Related]
16. Retinoic Acid Increases Fatty Acid Oxidation and Irisin Expression in Skeletal Muscle Cells and Impacts Irisin In Vivo.
Amengual J; García-Carrizo FJ; Arreguín A; Mušinović H; Granados N; Palou A; Bonet ML; Ribot J
Cell Physiol Biochem; 2018; 46(1):187-202. PubMed ID: 29587291
[TBL] [Abstract][Full Text] [Related]
17. FNDC5 could be regulated by leptin in adipose tissue.
Gutierrez-Repiso C; Garcia-Serrano S; Rodriguez-Pacheco F; Garcia-Escobar E; Haro-Mora JJ; Garcia-Arnes J; Valdes S; Gonzalo M; Soriguer F; Moreno-Ruiz FJ; Rodriguez-Cañete A; Martinez-Ferriz A; Santoyo JS; Perez-Valero V; Garcia-Fuentes E
Eur J Clin Invest; 2014 Oct; 44(10):918-25. PubMed ID: 25112714
[TBL] [Abstract][Full Text] [Related]
18. [Serum Myokines Levels in Patients with Endogenous Cushing Syndrome and Acromegaly: Cross-Sectional Case−Control Study].
Kolesnikova LI; Madaeva IM; Semenova NV; Osipova EV; Darenskaya MA
Vestn Ross Akad Med Nauk; 2016; 71(3):240-7. PubMed ID: 29297640
[TBL] [Abstract][Full Text] [Related]
19. The effect of sleeve gastrectomy on serum irisin levels in patients with morbid obesity.
Demirpence M; Yilmaz H; Colak A; Yalcin H; Toprak B; Turkon H; Ugurlu L; Aydin C
Endokrynol Pol; 2016; 67(5):481-486. PubMed ID: 26884298
[TBL] [Abstract][Full Text] [Related]
20. Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?
García-Fontana B; Reyes-García R; Morales-Santana S; Ávila-Rubio V; Muñoz-Garach A; Rozas-Moreno P; Muñoz-Torres M
Endocrine; 2016 Apr; 52(1):54-62. PubMed ID: 26438394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
